FDA Approves First Combination Inhaled Corticosteroid for Asthma
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.

Updates From 2022 GOLD International COPD Conference
In this podcast, Gerard J. Criner, MD, provides an overview of the recent revisions made to the GOLD report, including the strategy for the diagnosis, management, and prevention of COPD and issues surrounding COPD guidance that should be updated in the future.

Influenza, COVID-19, RSV: The Triple Threat of Winter 2022-2023: Women Leaders in Medicine, Ep. 16
In this virtual roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Amina Ahmed, MD, Callie Dobbins, RN, MSN, Katie Passaretti, MD, and Lisa Davidson, MD, about influenza, COVID-19, and respiratory syncytial virus (RSV), distinguishing the symptoms and clinical manifestations, managing changing guidelines and new information, and staffing and capacity issues.

COVID-19, Influenza, Respiratory Syncytial Virus in Pediatrics
In this podcast, John Harrington, MD, speaks about the “triple threat” of viral respiratory infections in children during the winter of 2022-2023, including COVID-19, influenza, and respiratory syncytial virus (RSV). He also addresses the children’s medicine shortage happening in some communities across the country and how he is advising the parents/guardians of his sick pediatric patients.

The State of Tobacco Control: Critical Observations in Pulmonary Medicine, Ep. 9
In this episode, Dr Rizzo interviews Scott D Siegel, PhD, MHCDS, and Thomas Carr about issues surrounding the most preventable cause of lung disease: tobacco, including the American Lung Association’s “State of Tobacco Control” annual report and research on the impact of smoking on communities of color.